Literature DB >> 16283158

Statins: the next step in adjuvant therapy for sepsis?

Armand Mekontso-Dessap, Christian Brun-Buisson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16283158     DOI： 10.1007/s00134-005-2860-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  24 in total

Review 1.  The pathogenesis of vasodilatory shock.

Authors:  D W Landry; J A Oliver
Journal:  N Engl J Med       Date:  2001-08-23       Impact factor: 91.245

2.  In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products.

Authors:  L Diomede; D Albani; M Sottocorno; M B Donati; M Bianchi; P Fruscella; M Salmona
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-08       Impact factor: 8.311

3.  Statin treatment after onset of sepsis in a murine model improves survival.

Authors:  Marc W Merx; Elisa A Liehn; Jürgen Graf; Annette van de Sandt; Maren Schaltenbrand; Jürgen Schrader; Peter Hanrath; Christian Weber
Journal:  Circulation       Date:  2005-07-05       Impact factor: 29.690

4.  Statin therapy is associated with fewer deaths in patients with bacteraemia.

Authors:  Peter Kruger; Kenneth Fitzsimmons; David Cook; Mark Jones; Graeme Nimmo
Journal:  Intensive Care Med       Date:  2005-11-10       Impact factor: 17.440

5.  Simvastatin prevents vascular hyporeactivity during inflammation.

Authors:  Johannes Pleiner; Georg Schaller; Friedrich Mittermayer; Stefan Zorn; Claudia Marsik; Stefan Polterauer; Stylianos Kapiotis; Michael Wolzt
Journal:  Circulation       Date:  2004-11-01       Impact factor: 29.690

6.  Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis.

Authors:  H Ando; T Takamura; T Ota; Y Nagai; K Kobayashi
Journal:  J Pharmacol Exp Ther       Date:  2000-09       Impact factor: 4.030

7.  Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro.

Authors:  Robert Kleemann; Lars Verschuren; Bert-Jan de Rooij; Jan Lindeman; Moniek M de Maat; Alexander J Szalai; Hans M G Princen; Teake Kooistra
Journal:  Blood       Date:  2004-02-19       Impact factor: 22.113

8.  Prior statin therapy is associated with a decreased rate of severe sepsis.

Authors:  Yaniv Almog; Alexander Shefer; Victor Novack; Nimrod Maimon; Leonid Barski; Miruna Eizinger; Michael Friger; Lior Zeller; Abraham Danon
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

9.  HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis.

Authors:  Marc W Merx; Elisa A Liehn; Uwe Janssens; Rudolf Lütticken; Jürgen Schrader; Peter Hanrath; Christian Weber
Journal:  Circulation       Date:  2004-05-03       Impact factor: 29.690

Review 10.  Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.

Authors:  Robert Krysiak; Boguslaw Okopień; Zbigniew Herman
Journal:  Drugs       Date:  2003       Impact factor: 9.546
View more
  11 in total

1.  Statins for sepsis: a cautionary note.

Authors:  Angus Vincent; James A L Miller
Journal:  Intensive Care Med       Date:  2006-03-21       Impact factor: 17.440

2.  Atorvastatin Relieves Cognitive Disorder After Sepsis Through Reverting Inflammatory Cytokines, Oxidative Stress, and Neuronal Apoptosis in Hippocampus.

Authors:  Jianmei Tian; Yongjie Tai; Mengrao Shi; Chunxiu Zhao; Wenwen Xu; Xuhua Ge; Guoji Zhu
Journal:  Cell Mol Neurobiol       Date:  2019-11-06       Impact factor: 5.046

3.  Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome.

Authors:  Hendrik Schmidt; Ralf Hennen; Alexander Keller; Martin Russ; Ursula Müller-Werdan; Karl Werdan; Michael Buerke
Journal:  Intensive Care Med       Date:  2006-06-21       Impact factor: 17.440

4.  Predictors of hospital-acquired urinary tract-related bloodstream infection.

Authors:  M Todd Greene; Robert Chang; Latoya Kuhn; Mary A M Rogers; Carol E Chenoweth; Emily Shuman; Sanjay Saint
Journal:  Infect Control Hosp Epidemiol       Date:  2012-08-23       Impact factor: 3.254

Review 5.  Are there any benefits from statin treatment for the septic patient?

Authors:  Peter S Kruger; Bala Venkatesh
Journal:  Curr Atheroscler Rep       Date:  2014-01       Impact factor: 5.113

6.  Effects of discontinuing or continuing ongoing statin therapy in severe sepsis and septic shock: a retrospective cohort study.

Authors:  Armand Mekontso Dessap; Islem Ouanes; Nerlep Rana; Beatrice Borghi; Christophe Bazin; Sandrine Katsahian; Anne Hulin; Christian Brun-Buisson
Journal:  Crit Care       Date:  2011-07-18       Impact factor: 9.097

7.  Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis: comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin.

Authors:  Daniel R Ouellette; Erics Espinoza Moscoso; Julio Pinto Corrales; Michael Peters
Journal:  Ann Intensive Care       Date:  2015-05-06       Impact factor: 6.925

8.  The Effects of Atorvastatin on Inflammatory Responses and Mortality in Septic Shock: A Single-center, Randomized Controlled Trial.

Authors:  Ratender Kumar Singh; Vikas Agarwal; Arvind Kumar Baronia; Sudeep Kumar; Banani Poddar; Afzal Azim
Journal:  Indian J Crit Care Med       Date:  2017-10

Review 9.  The effects of statin therapy on mortality in patients with sepsis: A meta-analysis of randomized trials.

Authors:  Mengyan Chen; Mingxia Ji; Xiaoshui Si
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

10.  Impact of prior statin use on mortality in patients with type 2 diabetes mellitus and bloodstream infection.

Authors:  Chi-Yung Cheng; Chia-Te Kung; Fu-Cheng Chen; Hsien-Hung Cheng; Tsung-Cheng Tsai; Sheng-Yuan Hsiao; Chih-Min Su
Journal:  J Int Med Res       Date:  2019-06-25       Impact factor: 1.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.